New shot aims to control stubborn hepatitis b virus
NCT ID NCT06993480
Summary
This study is testing an experimental injection called AHB-137 in people who already take standard pills for chronic hepatitis B. The goal is to see if the new treatment can further reduce the amount of virus in the blood and strengthen the body's immune response against it. About 30 adults will receive the injection for 24 weeks and be followed for another 24 weeks to monitor their health and the treatment's effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Affiliated Hospital of Chongqing Medical University
RECRUITINGChongqing, Chongqing Municipality, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.